Hanmi Pharm registers ‘Esomezol’

‘Esomezol,’ an acid reflux treatment developed by Hanmi Pharm, was registered at the U.S. Pharmacopeial(USP) for the first time as a Korean pharmaceutical company. Esomezol is the Korea’s first incrementally modified drug acquiring commercialization approval from the U.S. FDA.

Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) announced on the 19^th that Esomeprazole Strontium, a substance of Esomez...